Precigen, Inc. (PGEN)
Nasdaq: PGEN · Pharmaceutical Preparations · Germantown, MD · filing with the SEC since 2006
Who owns Precigen, Inc.
As filed with the SECHolders of 5% or more
3
Randal J. Kirk holds 35.9% of Common Stock, as its SCHEDULE 13D/A filed Mar 31, 2026 says.
Directors and officers
13
report now, of 31 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Randal J. Kirk
SCHEDULE 13D/A · filed Mar 31, 2026 · Common Stock · 38.1% in Nov 21, 2025
Patient Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock · 13.6% in Oct 30, 2025
William H. Miller III Living Trust dated April 17, 2017
SCHEDULE 13G · filed Sep 23, 2025 · Common Stock
Ares Trading SA
SCHEDULE 13G/A · filed Aug 7, 2026 · Common Stock · reported falling below 5%
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, no par value per share · reported falling below 5%, from 5.2% in Jan 23, 2026
What PGEN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
ActoBio Therapeutics Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 25, 2026
5 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 25, 2026.
Insider tradesForm 4
42sales
1purchases
10sales on a scheduled plan
7people selling
$44.8Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 33 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kirk Randal J | Executive Chairman | 26 | $42.2M | 0 | 0 | $0 |
| Sabzevari Helen | President and CEO | 2 | $2.6M | 1 | 0 | $0 |
| Kindler Jeffrey B | director | 3 | $2.6M | 0 | 0 | $0 |
| Thomasian Harry Jr. | Chief Financial Officer | 4 | $1.9M | 3 | 0 | $0 |
| Shah Rutul R | Chief Operating Officer | 6 | $1.3M | 5 | 0 | $0 |
| Tennant Phil | Chief Commercial Officer | 2 | $700,000 | 1 | 0 | $0 |
| Lehr Donald P. | Chief Legal Officer | 1 | $100,000 | 0 | 0 | $0 |
| Agee Nancy H | director | 0 | $0 | 0 | 1 | $0 |